David Small

2.3k total citations
68 papers, 1.8k citations indexed

About

David Small is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, David Small has authored 68 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pulmonary and Respiratory Medicine, 32 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in David Small's work include Lung Cancer Treatments and Mutations (22 papers), Lung Cancer Diagnosis and Treatment (12 papers) and Colorectal Cancer Treatments and Studies (7 papers). David Small is often cited by papers focused on Lung Cancer Treatments and Mutations (22 papers), Lung Cancer Diagnosis and Treatment (12 papers) and Colorectal Cancer Treatments and Studies (7 papers). David Small collaborates with scholars based in Canada, United States and Spain. David Small's co-authors include Harvey Kreisman, Goulnar Kasymjanova, Jason Agulnik, Norman Wolkove, Victor Cohen, Carmela Pepe, Esther Dajczman, Élisabeth Quoix, Anne Charloux and Mary A.M. Rogers and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Annals of Internal Medicine.

In The Last Decade

David Small

66 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Small Canada 22 766 622 299 191 162 68 1.8k
Silvio Cavuto Italy 25 898 1.2× 424 0.7× 108 0.4× 267 1.4× 152 0.9× 72 2.4k
Ted Wun United States 28 240 0.3× 392 0.6× 454 1.5× 284 1.5× 225 1.4× 75 2.9k
Aruna Kamineni United States 28 651 0.8× 1.4k 2.2× 314 1.1× 479 2.5× 183 1.1× 93 2.6k
Marisa Baré Spain 24 432 0.6× 649 1.0× 92 0.3× 197 1.0× 65 0.4× 92 1.5k
Luigi Santoro Italy 26 318 0.4× 679 1.1× 589 2.0× 512 2.7× 160 1.0× 77 2.3k
Maureen P. Neary United States 25 538 0.7× 717 1.2× 96 0.3× 362 1.9× 263 1.6× 111 2.4k
Tineke J. Smilde Netherlands 25 524 0.7× 631 1.0× 299 1.0× 629 3.3× 319 2.0× 71 2.3k
Sally Wade United States 21 219 0.3× 624 1.0× 155 0.5× 511 2.7× 259 1.6× 43 2.5k
Aya Mitani United States 20 295 0.4× 336 0.5× 133 0.4× 270 1.4× 114 0.7× 60 1.2k
Sinna Pilgaard Ulrichsen Denmark 19 507 0.7× 157 0.3× 250 0.8× 186 1.0× 147 0.9× 50 1.5k

Countries citing papers authored by David Small

Since Specialization
Citations

This map shows the geographic impact of David Small's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Small with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Small more than expected).

Fields of papers citing papers by David Small

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Small. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Small. The network helps show where David Small may publish in the future.

Co-authorship network of co-authors of David Small

This figure shows the co-authorship network connecting the top 25 collaborators of David Small. A scholar is included among the top collaborators of David Small based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Small. David Small is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Agulnik, Jason, Andreas I. Papadakis, Carmela Pepe, et al.. (2022). Cell-Free Tumor DNA (ctDNA) Utility in Detection of Original Sensitizing and Resistant EGFR Mutations in Non-Small Cell Lung Cancer (NSCLC). Current Oncology. 29(2). 1107–1116. 6 indexed citations
2.
Agulnik, Jason, Goulnar Kasymjanova, Pierre Fiset, et al.. (2019). The metastatic site does not influence PD-L1 expression in advanced non-small cell lung carcinoma. Lung Cancer. 132. 36–38. 19 indexed citations
3.
Kasymjanova, Goulnar, R. Thomas Jagoe, Carmela Pepe, et al.. (2018). Does the Presence of Emphysema Increase the Risk of Radiation Pneumonitis in Lung Cancer Patients?. Current Oncology. 25(6). 610–614. 6 indexed citations
4.
Kempen, Léon C.L.T. van, Hangjun Wang, Alan Spatz, et al.. (2018). Afatinib in Osimertinib-Resistant EGFR ex19del/T790M/P794L Mutated NSCLC. Journal of Thoracic Oncology. 13(9). e161–e163. 10 indexed citations
5.
Hudson, Marie, et al.. (2018). A case of severe Pembrolizumab-induced neutropenia. Anti-Cancer Drugs. 29(8). 817–819. 24 indexed citations
6.
Agulnik, Jason, Goulnar Kasymjanova, V. Cohen, et al.. (2018). Cytology cell blocks are suitable for immunohistochemical testing for PD-L1 in lung cancer. Annals of Oncology. 29(6). 1417–1422. 84 indexed citations
7.
Kasymjanova, Goulnar, David Small, V. Cohen, et al.. (2017). Lung Cancer Care Trajectory at a Canadian Centre: An Evaluation of How Wait Times Affect Clinical Outcomes. Current Oncology. 24(5). 302–309. 33 indexed citations
8.
9.
Hoffer, L. John, Line Robitaille, Robert Zakarian, et al.. (2015). High-Dose Intravenous Vitamin C Combined with Cytotoxic Chemotherapy in Patients with Advanced Cancer: A Phase I-II Clinical Trial. PLoS ONE. 10(4). e0120228–e0120228. 88 indexed citations
10.
Sakr, Lama, David Small, Goulnar Kasymjanova, Samy Suissa, & Pierre Ernst. (2015). Phenotypic Heterogeneity of Potentially Curable Non–Small-Cell Lung Cancer: Cohort Study with Cluster Analysis. Journal of Thoracic Oncology. 10(5). 754–761. 7 indexed citations
11.
Kasymjanova, Goulnar, Chantal Robitaille, Victor Cohen, et al.. (2014). Comparison of the Yield of Different Diagnostic Procedures for Cellular Differentiation and Genetic Profiling of Non–Small-Cell Lung Cancer. Journal of Thoracic Oncology. 9(8). 1120–1125. 7 indexed citations
12.
Kasymjanova, Goulnar, José A. Correa, Harvey Kreisman, et al.. (2009). Prognostic Value of the Six-Minute Walk in Advanced Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 4(5). 602–607. 116 indexed citations
13.
Dajczman, Esther, et al.. (2008). Should Patient-Rated Performance Status Affect Treatment Decisions in Advanced Lung Cancer?. Journal of Thoracic Oncology. 3(10). 1133–1136. 57 indexed citations
14.
Eisen, Tim, Nick Thatcher, Serge Leyvraz, et al.. (2008). Phase II study of weekly plitidepsin as second-line therapy for small cell lung cancer. Lung Cancer. 64(1). 60–65. 23 indexed citations
15.
16.
Rogers, Mary A.M., et al.. (2001). Home Monitoring Service Improves Mean Arterial Pressure in Patients with Essential Hypertension: A Randomized Controlled Trial. Circulation. 103. 1369–1370. 3 indexed citations
17.
Charloux, Anne, Michel Rossignol, Ashok Purohit, et al.. (1997). International differences in epidemiology of lung adenocarcinoma. Lung Cancer. 16(2-3). 133–143. 39 indexed citations
18.
Vetter, N, David Stamler, Sean O’Neill, et al.. (1997). Clarithromycin vs Combined Cefuroxime and Erythromycin in the Treatment of Hospitalised Community-Acquired Pneumonia Patients - Intravenous Followed by Oral Therapy. Clinical Drug Investigation. 14(6). 439–449. 6 indexed citations
19.
Rivington, Robert N., L.P. Boulet, Julie Anne Côté, et al.. (1995). Efficacy of Uniphyl, Salbutamol, and Their Combination in Asthmatic Patients on High-Dose Inhaled Steroids. American Journal of Respiratory and Critical Care Medicine. 151(2). 325–332. 58 indexed citations
20.
Small, David, et al.. (1994). Jejunobronchial Fistula: Case Report and Brief Discussion of the Literature. Mayo Clinic Proceedings. 69(11). 1082–1084. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Silvio Cavuto Breakdown of academic impact, for papers by Ted Wun Breakdown of academic impact, for papers by Aruna Kamineni Breakdown of academic impact, for papers by Marisa Baré Breakdown of academic impact, for papers by Luigi Santoro Breakdown of academic impact, for papers by Maureen P. Neary Breakdown of academic impact, for papers by Tineke J. Smilde Breakdown of academic impact, for papers by Sally Wade Breakdown of academic impact, for papers by Aya Mitani Breakdown of academic impact, for papers by Sinna Pilgaard Ulrichsen
Rankless by CCL
2026